Company: OCG
Filing Date: 2025-12-11
Form Type: 424B5
Source: 0001213900-25-120719
Chunk: 25

Company: Oriental Culture Holding LTD
Filing Date: 2025-12-11
Form: 424B5
Chunk 25
---
 may be made from time to time through our sales agent, A.G.P See “Plan of Distribution.”                                   |
| Use of proceeds                              |     | We intend to use the net                                                                                                                 
 proceeds of this offering primarily for the working capital and growth capital purposes. See “Use of Proceeds” on Page                   
 S-11 of this prospectus supplement.                                                                                                      |
| Risk factors                                 |     | Investing in our securities                                                                                                              
 involves a high degree of risk. For a discussion of factors, you should consider carefully before deciding to invest in our securities,  
 see the information contained in or incorporated by reference under the heading “Risk Factors” beginning on page S-8                     
 of this prospectus supplement and in the other documents incorporated by reference into this prospectus supplement.                      |
| Listing                                      |     | Our Ordinary Shares are                                                                                                                  
 listed on the Nasdaq Capital Market under the symbol “OCG.”                                                                              |
|                                              |     | The number of ordinary shares outstanding after this offering is based                                                                   
 on 21,233,927 Ordinary Shares outstanding as of December 10, 2025 and excludes, as of such date: 1,247,000 Ordinary Shares issuable upon 
 exercise of warrants at an exercise price of $0.50 per share.                                                                            |

<div align='center'>S-7

RISK FACTORS</div>

Investing in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should carefully consider the risk factors we describe in this prospectus supplement and the accompanying prospectus, and in any prospectus that we may authorize to be provided to you or in any report incorporated by reference into this prospectus supplement and the accompanying prospectus, and the 2024 Form 20-F Annual Report or any report of foreign private issuer on Form 6-K that is incorporated by reference into this prospectus supplement and the accompanying prospectus. Although we discuss key risks in those risk factor descriptions, additional risks not currently known to us or that we currently deem immaterial also may impair our business. Our subsequent filings with the SEC may contain amended and updated discussions of significant risks. We cannot predict future risks or estimate the extent to which they may affect our financial performance.

Risks Related to This Offering

The Ordinary Shares offered hereby will be sold in “at the market” offerings, and investors who buy the shares at different times will likely pay different prices.

Sales of the Ordinary Shares, if any, under this
prospectus supplement and the